Unassigned Industry (31) | Collaboration Agreements (672)

Browse by Company

Recent Contracts

Amendment No. 1 to License and Collaboration Agreement between Felicitex Therapeutics Inc. and Diaxonhit, dated July 21, 2014 (Felicitex Therapeutics Inc., Filed With SEC on August 10, 2022)
License and Collaboration Agreement between Felicitex Therapeutics Inc. and Diaxonhit, dated April 16, 2014 (Felicitex Therapeutics Inc., Filed With SEC on August 10, 2022)
Amendment No. 2 to License and Collaboration Agreement between Felicitex Therapeutics Inc. and Eurobio Scientific SA (formerly Diaxonhit), dated February 14, 2022 (Felicitex Therapeutics Inc., Filed With SEC on August 10, 2022)
English Translation of Form Regional Service Provider Collaboration Agreement dated July 31, 2022 (Gushen, Inc, Filed With SEC on August 3, 2022)
Research and Development Collaboration Agreement, by and between the Registrant and Arpeggio Biosciences, Inc., dated December 22, 2020 (Intrinsic Medicine, Inc., Filed With SEC on April 8, 2022)
Research and Development Collaboration Agreement, dated as of December 14, 2021, by and between TeleSign and Proximus (NAAC Holdco, Inc., Filed With SEC on March 21, 2022)
Strategic Collaboration and License Agreement by and between the Registrant and Vertex Pharmaceuticals Incorporated., dated as of April 14, 2020 (Affinia Therapeutics Inc., Filed With SEC on January 4, 2022)
Collaboration Agreement by and among the Registrant and Rheinische Friedrich-Wilhelms-Universitt Bonn and Universittsklinikum Bonn, dated as of June 11, 2021 (Affinia Therapeutics Inc., Filed With SEC on January 4, 2022)
Sponsored Research Collaboration Agreement by and between the Registrant and The Institute of Molecular and Clinical Ophthalmology Basel, dated as of June 22, 2021 (Affinia Therapeutics Inc., Filed With SEC on January 4, 2022)
Amendment No. 1 to Strategic Collaboration Agreement, dated October 18, 2021, by and between the Registrant and Affimed GmbH (Artiva Biotherapeutics, Inc., Filed With SEC on December 16, 2021)